Differences between clinical trial efficacy and real-world effectiveness.
about
Preexposure prophylaxis for HIV prevention: where have we been and where are we going?Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.Comparative effectiveness of guidelines for the management of hyperlipidemia and hypertension for type 2 diabetes patients.Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis.The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings.Adherence to lipid-lowering treatment: the patient perspective.Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factorsNovel methods for tracking long-term maintenance immunosuppression regimens.Clinical efficacy and safety of statins in managing cardiovascular risk.Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis.Direct-acting antiviral agents in patients with hepatitis C cirrhosis.Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab.Lessons learned in the development and evaluation of RxCoach™, an mHealth app to increase tobacco cessation medication adherence.Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease.
P2860
Q26825042-14E2D9DA-BE2B-4A14-A866-B6E8CB6063EBQ33691594-4A220F0B-EFCC-4EE4-9FA0-A5A0CAF7A2E4Q33808664-266A823C-13ED-4545-84DD-8E669B78E8DBQ34105982-AC114901-5569-4FB6-A456-DCCA30E18AC8Q35843906-85F1F5D2-AC15-4B85-BD92-C253FE16BA13Q36394334-D74B70DC-2BB9-4CE2-9DC8-39A5D732619EQ36536210-513BD31D-331F-4014-B7BA-314D94C72FF2Q36666963-371722EF-494C-469E-80BC-873DD5825E39Q36812806-DE4607BE-34D9-41E9-AE29-34A18FC6E17EQ37223505-3EDCD5F3-48BC-4628-BCDB-9FD5FF7325B5Q37663921-D7CFDA66-D035-4489-87AA-71DE3A4BC42BQ48520571-C8B0D1A9-729E-428E-80CD-0EED69F0F030Q54202672-D64A148B-A902-4F62-A091-9CDCE9D9E257Q55429175-604C8BED-E497-458B-90C8-D02CD32FD24F
P2860
Differences between clinical trial efficacy and real-world effectiveness.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Differences between clinical trial efficacy and real-world effectiveness.
@ast
Differences between clinical trial efficacy and real-world effectiveness.
@en
type
label
Differences between clinical trial efficacy and real-world effectiveness.
@ast
Differences between clinical trial efficacy and real-world effectiveness.
@en
prefLabel
Differences between clinical trial efficacy and real-world effectiveness.
@ast
Differences between clinical trial efficacy and real-world effectiveness.
@en
P1476
Differences between clinical trial efficacy and real-world effectiveness.
@en
P2093
Michael H Davidson
P304
P433
P577
2006-11-01T00:00:00Z